Original Article

Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals
  • Sibel YILDIZ KAYA
  • Bilgül METE
  • Abdurrahman KAYA
  • Ilker Inanç BALKAN
  • Nese SALTOGLU
  • Fehmi TABAK
Viral Hepat J 2017; 23: 6-9 DOI: 10.4274/vhd.52724

Research Article

Long-term Sustained Virological Response Rate in Treatment of Chronic Hepatitis C Patients
  • Mustafa SÜNBÜL
  • Tuba KURUOĞLU
  • İsmail Hakkı DÜNDAR
  • Şaban ESEN
  • Cafer EROĞLU
  • Hakan LEBLEBİCİOĞLU
Viral Hepat J 2008; 13: 7-11
A Comparison of Interferon α-2a Plus Ribavirin Combination Therapy with Peginterferon α-2a Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
  • Hayati DEMİRASLAN
  • Bilgehan AYGEN
  • Orhan YILDIZ
  • Işın SOYUER
  • Selma GÖKAHMETOĞLU
Viral Hepat J 2008; 13: 12-22
IFN-a2b Induction Treatment with Ribavirin in Patients with Chronic Hepatitis C
  • Yunus GÜRBÜZ
  • Ediz TÜTÜNCÜ
  • Ruçhan TÜRKYILMAZ
Viral Hepat J 2005; 10: 15-18
The Effectivity of Combination of Standard Interferon-a + Ribavirin and Pegylated Interferon-a + Ribavirin Therapy in Patients with Chronic Hepatitis C
  • Nail ÖZGÜNES
  • Fatma SARGIN
  • Saadet YAZICI
  • Nüket CEYLAN
  • Ayse Canan ÜÇISIK
  • Pinar ERGEN
  • Arzu DOGRU
  • Özlem AYDIN
Viral Hepat J 2006; 11: 61-64
Evaluation of 219 Patients with Chronic Hepatitis C Receiving Pegylated Interferon + Ribavirin Treatment
  • Nevil AYKIN
  • Figen ÇAĞLAN ÇEVİK
  • Hasan NAZ
  • Pınar KORKMAZ
  • Tercan US
Viral Hepat J 2013; 19: 71-75 DOI: 10.4274/Vhd.77486
Hepatitis C Prevalence and Responses to Pegylated Interferon + Ribavirin Treatment Among Prisoners
  • Hasan Selçuk ÖZGER
  • Ömer KARAŞAHİN
  • Mehmet Armağan TOY
  • Sibel İBA YILMAZ
  • Kenan HIZEL
Viral Hepat J 2017; 23: 71-75 DOI: 10.4274/vhd.0007
Evaluation of Sustained Virological Response in Patients with Genotype 1b Chronic Hepatitis C Infection
  • Esragül AKINCI
  • Bircan ÜNAL KAYAASLAN
  • Aliye TANRICI BAŞBUĞ
  • Selim Sırrı EREN
  • Pınar ÖNGÜRÜ
  • Hürrem BODUR
Viral Hepat J 2013; 19: 80-84 DOI: 10.4274/Vhd.68077
Skin Disease after Chronic Hepatitis C: Two Cases Report
  • Yunus GÜRBÜZ
  • Emin Ediz TÜTÜNCÜ
  • Doğan Barış ÖZTÜRK
  • Ayşe BAYLAK
  • İrfan ŞENCAN
Viral Hepat J 2011; 17: 84-87
Comparison of the Efficacy of Standard Interferon Alpha 2a Plus Ribavirin and PegylatedInterferon Alpha 2a Plus Ribavirin Combination Therapies in the Treatment of ChronicHepatitis C Infection
  • Şua SÜMER
  • Onur URAL
  • Nazlım AKTUĞDEMİR
  • Gaye URAL
  • Mehmet BALCI
  • Nebahat DİKİCİ
Viral Hepat J 2009; 14: 89-90
Combination of Interferon Induction Therapy and Ribavirin in Chronic Hepatitis C Patients: Results of a Multicenter Clinical Trial
  • Bilgehan AYGEN
  • Orhan YILDIZ
  • Rahmet ÇAYLAN
  • Iftihar KÖKSAL
  • Nese SALTOGLU
  • Yesim TASOVA
  • Hakan LEBLEBICIOGLU
  • Saban ESEN
Viral Hepat J 2004; 9: 123-129

Case Report

Chronic Hepatitis C Treatment-Related Skin Rash: A Report of Two Cases
  • Tuğba ARSLAN GÜLEN
  • Ayfer İMRE
Viral Hepat J 2015; 21: 59-61 DOI: 10.4274/vhd.96268
Dermatological Side Effects in a Patient with Hepatitis C Infection During Treatment with Pegylated Interferon/Ribavirin+Telaprevir: A Case Report
  • Tugba SARI
  • Suda Tekin KORUK
  • Fatih TEMOÇIN
Viral Hepat J 2014; 20: 81-84 DOI: 10.4274/vhd.38358
Sensorineural Hearing Loss Due to Pegylated Interferon Alfa/Ribavirin Therapy: A Case Report
  • Tuğba SARI
  • Süda TEKİN KORUK
  • Alaaddin ZİREK
Viral Hepat J 2012; 18: 123-125 DOI: 10.4274/Vhd.66376
Chronic Hepatitis C Treatment in a Thalassemia Major Patient: A Case Report
  • Kaya Hüseyin Süer
  • Dilara İnan
Viral Hepat J 2014; 20: 134-137 DOI: 10.4274/vhd.83803

Letter to the Editor

Paradoxes in Novel Hepatitis C Therapies: Is Combination of Sofosbuvir and Ribavirin Without Interferon Effective in Genotype 1b Chronic HCV Patients?
  • Ergenekon KARAGÖZ
  • Vedat TURHAN
  • Asim ÜLÇAY
  • Alpaslan TANOĞLU
  • Hakan ERDEM
Viral Hepat J 2015; 21: 62-64 DOI: 10.4274/vhd.33042

Other

CHRONIC HEPATIT C TREATMENT WITH INTERFERON ALPHA 2b-RIBAVIRIN COMBINATION THERAPY
  • Ismail BALIK
  • Osman MEMIKOGLU
Viral Hepat J 2001; 7: 0-0
Long-Term Follow-Up of Hepatitis C Patients with Virological and Biochemical Response to Therapy and Investigation of Factors Predicting Relapses
  • Bahadir CEYLAN
  • Muzaffer FINCANCI
  • Cüneyt MUDERRISOGLU
  • Ferda SOYSAL
  • Gülhan EREN
Viral Hepat J 2007; 12: 14-23
A Case of Erythema Multiforme Related to Pegylated Interferon-a2a Plus Ribavirin Treatment for Chronic Hepatitis C Virus Infection
  • Ilhan ÖZGÜNES
  • Elif DOYUK KARTAL
  • Nurettin ERBEN
  • Saygin NAYMAN ALPAT
  • Gaye USLUER
Viral Hepat J 2006; 11: 101-104
Comparison of the Effect of Standard IFN-a Treatment and Standard IFN-a plus Ribavirin Therapy in Patients with Naive Chronic Hepatitis C
  • Nail ÖZGÜNES
  • Fatma SARGIN
  • Saadet YAZICI
  • Ayse Canan ÜÇISIK
  • Nüket CEYLAN
  • Pinar ERGEN
  • Özlem AYDIN
  • Arzu DOGRU
Viral Hepat J 2005; 10: 135-138

About Journal

Forms

Useful Links

Applications